NCT07317687 Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic
| NCT ID | NCT07317687 |
| Status | Recruiting |
| Phase | — |
| Sponsor | West Virginia University |
| Condition | HIV Testing |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-01-21 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2026-01-21 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
West Virginia faces rising rates of HIV, hepatitis, and syphilis, particularly among individuals experiencing homelessness, substance use, and mental health challenges. Traditional blood-draw testing for these infections is often hindered by mistrust, logistical barriers, and delays in results. This study, conducted by the West Virginia University (WVU) Street Medicine program, evaluates a rapid, point-of-care fingerstick test for HIV, Hepatitis C, and syphilis that provides results within 10-20 minutes during mobile clinic visits. Participants may choose rapid testing, traditional blood draw (which also includes Hepatitis B screening), or decline testing. All participants will be invited to complete a brief survey about the experiences with screening methods. The goal is to assess whether rapid testing improves screening uptake, linkage to care, and patient satisfaction, ultimately reducing barriers and disease burden in high-risk populations.
Eligibility Criteria
Inclusion Criteria: * Patients of the WVU Medicine Street Medicine team Exclusion Criteria: * Patients under the age of 18
Contact & Investigator
Dana Bechtold, DO
PRINCIPAL INVESTIGATOR
West Virginia University
Frequently Asked Questions
Who can join the NCT07317687 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV Testing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07317687 currently recruiting?
Yes, NCT07317687 is actively recruiting participants. Contact the research team at dana.bechtold@hsc.wvu.edu for enrollment information.
Where is the NCT07317687 trial being conducted?
This trial is being conducted at Harpers Ferry, United States.
Who is sponsoring the NCT07317687 clinical trial?
NCT07317687 is sponsored by West Virginia University. The principal investigator is Dana Bechtold, DO at West Virginia University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.